T Uemura

No ORCID on file · 6 papers in corpus
other 1999
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/j.1447-0756.1999.tb01166.x

OBJECTIVE: In order to examine whether treatment with a GnRH agonist alone can maintain estrogen levels within the "estrogen window" that inhibits endometriosis without influencing bone-mineral density, we studied the effects of GnRH agonis…

article 1999
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/j.1447-0756.1999.tb01141.x

OBJECTIVES: This multicenter prospective study of buserelin acetate (Suprecur) therapy for endometriosis was performed in order to examine pregnancy rates and the recurrence of endometriosis 1 year after the end of intranasal administration…

article 1994
Fertility and sterility ·doi:10.1016/s0015-0282(16)56873-3

ObjectiveTo examine changes in bone mineral density (BMD) of patients treated with GnRH agonist (GnRH-a) by dual-energy X-ray absorptiometry and to understand factors related to bone loss.DesignProspective controlled trial examining BMD dur…

other 1992
American journal of obstetrics and gynecology ·doi:10.1016/s0002-9378(11)91676-7

OBJECTIVE: We investigated the mechanisms of desensitization induced by gonadotropin-releasing hormone agonist in the pituitary. STUDY DESIGN: Effects of gonadotropin-releasing hormone agonist on the pituitary were studied in vitro and in …

article 1986
Progress in clinical and biological research
article 1985
Asia-Oceania journal of obstetrics and gynaecology ·doi:10.1111/j.1447-0756.1985.tb00051.x

Abstract Two cases of catamenial pneumothorax treated with danazol, an isoxazole derivative of 17α‐ethinyl testosterone, are reported. The first patient, a 44‐year‐old woman who had had 31 attacks of spontaneous pneumothorax at the onset of…